Pharmaceutical Manufacturing Featured Editorial
-
Top Single-Use Suppliers Make Standardized Equipment A Reality – Part 2
5/8/2015
Industry experts offer the benefits of standardized single-use equipment to both suppliers and users, as well as how it addresses some of the biggest objections to equipment standardization, as well as offer insight from the eyes of a user.
-
ISPE Set To Address Drug Shortages At Annual Meeting
10/6/2014
Drug shortages continue to plague the pharmaceutical industry. According to a GAO report on shortages, dated February 2014, the number of shortages continues to increase in the U.S., as well as around the world. In 2007 there were 154 shortages, 114 new shortages and 40 ongoing from a prior year. In 2012, there were 456 shortages, 195 news ones and 261 ongoing. As of June 30, 2013, there were already 73 new shortages and 288 ongoing.
The public health importance of these shortages cannot be overemphasized. Shortage situations have included zinc for parenteral nutrition in neonates and premature infants, doxorubicin for ovarian and other cancers, and Propofol for anesthesia.
Clearly something needs to be done. “ISPE believes efforts to address this complex and multi-faceted problem of drug shortages requires close collaboration and clear communication between the pharma industry and global health authorities,” says Francois Sallans, VP and chief quality officer for Johnson & Johnson, and presenter at the 2014 ISPE-FDA CGMP Conference. “We believe The Drug Shortages Prevention Plan being assembled by ISPE will provide guidance to pharma and global health authorities to manage drug shortages more effectively. But more importantly we are looking into ways for the two groups to manage these shortages more proactively as well. That is an important component that we need to have in place in order to make these shortages rare, but short-lived.”
-
Maximize Return; Minimize Risk (Important Things To Consider When Closing A Lab)
6/3/2013
Whether a small enterprise or large institution, many organizations have and will be faced with the challenge of closing a lab. No matter what the size or scope of the closure, the person tasked with closing the facility faces a daunting assignment: millions of dollars in real estate, laboratory equipment, and research devices will need to be redeployed, sold, or disposed of. By Tom Burton, President Liquidity Services’ Capital Asset Group
-
Investigation Of New Level Technologies In Single Use, Disposable Systems
This article presents guided wave radar level measurement as an acceptable, less expensive alternate to load cell systems. By David Ladoski and Dan Klees